145 related articles for article (PubMed ID: 38457656)
21. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
22. Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study.
Devi A; Chaitanya NSN
Mol Divers; 2022 Feb; 26(1):157-169. PubMed ID: 33389440
[TBL] [Abstract][Full Text] [Related]
23. Glycosylation of Receptor Binding Domain of SARS-CoV-2 S-Protein Influences on Binding to Immobilized DNA Aptamers.
Grabovenko F; Nikiforova L; Yanenko B; Ulitin A; Loktyushov E; Zatsepin T; Zavyalova E; Zvereva M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008982
[TBL] [Abstract][Full Text] [Related]
24. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
[TBL] [Abstract][Full Text] [Related]
25. Xeno-Nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding.
Alves Ferreira-Bravo I; DeStefano JJ
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696413
[TBL] [Abstract][Full Text] [Related]
26. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
[TBL] [Abstract][Full Text] [Related]
27. Repurposing CRISPR/Cas to Discover SARS-CoV-2 Detecting and Neutralizing Aptamers.
Zhang J; Zhu A; Mei M; Qu J; Huang Y; Shi Y; Xue M; Zhang J; Zhang R; Zhou B; Tan X; Zhao J; Wang Y
Adv Sci (Weinh); 2023 Aug; 10(22):e2300656. PubMed ID: 37204115
[TBL] [Abstract][Full Text] [Related]
28. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
29. Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
Mironov V; Shchugoreva IA; Artyushenko PV; Morozov D; Borbone N; Oliviero G; Zamay TN; Moryachkov RV; Kolovskaya OS; Lukyanenko KA; Song Y; Merkuleva IA; Zabluda VN; Peters G; Koroleva LS; Veprintsev DV; Glazyrin YE; Volosnikova EA; Belenkaya SV; Esina TI; Isaeva AA; Nesmeyanova VS; Shanshin DV; Berlina AN; Komova NS; Svetlichnyi VA; Silnikov VN; Shcherbakov DN; Zamay GS; Zamay SS; Smolyarova T; Tikhonova EP; Chen KH; Jeng US; Condorelli G; de Franciscis V; Groenhof G; Yang C; Moskovsky AA; Fedorov DG; Tomilin FN; Tan W; Alexeev Y; Berezovski MV; Kichkailo AS
Chemistry; 2022 Feb; 28(12):e202104481. PubMed ID: 35025110
[TBL] [Abstract][Full Text] [Related]
30. Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection.
Sun M; Liu S; Wei X; Wan S; Huang M; Song T; Lu Y; Weng X; Lin Z; Chen H; Song Y; Yang C
Angew Chem Int Ed Engl; 2021 Apr; 60(18):10266-10272. PubMed ID: 33561300
[TBL] [Abstract][Full Text] [Related]
31. Discovery and Characterization of Spike N-Terminal Domain-Binding Aptamers for Rapid SARS-CoV-2 Detection.
Kacherovsky N; Yang LF; Dang HV; Cheng EL; Cardle II; Walls AC; McCallum M; Sellers DL; DiMaio F; Salipante SJ; Corti D; Veesler D; Pun SH
Angew Chem Int Ed Engl; 2021 Sep; 60(39):21211-21215. PubMed ID: 34328683
[TBL] [Abstract][Full Text] [Related]
32. Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease.
Ayass MA; Tripathi T; Griko N; Pashkov V; Dai J; Zhang J; Herbert FC; Ramankutty Nair R; Okyay T; Zhu K; Gassensmith JJ; Abi-Mosleh L
Virol J; 2022 Dec; 19(1):227. PubMed ID: 36581924
[TBL] [Abstract][Full Text] [Related]
33. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
Zhang S; Qiao S; Yu J; Zeng J; Shan S; Tian L; Lan J; Zhang L; Wang X
Nat Commun; 2021 Mar; 12(1):1607. PubMed ID: 33707453
[TBL] [Abstract][Full Text] [Related]
34. Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor.
Hameed NS; Arif IS; Al-Sudani BT
J Adv Pharm Technol Res; 2023; 14(3):185-190. PubMed ID: 37692001
[TBL] [Abstract][Full Text] [Related]
35. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.
Souza PFN; Mesquita FP; Amaral JL; Landim PGC; Lima KRP; Costa MB; Farias IR; Lima LB; Montenegro RC
Int J Biol Macromol; 2021 May; 179():1-19. PubMed ID: 33667553
[TBL] [Abstract][Full Text] [Related]
36. Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates.
Schrörs B; Riesgo-Ferreiro P; Sorn P; Gudimella R; Bukur T; Rösler T; Löwer M; Sahin U
PLoS One; 2021; 16(9):e0249254. PubMed ID: 34570776
[TBL] [Abstract][Full Text] [Related]
37. Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations.
Lim HJ; Park MY; Jung HS; Kwon Y; Kim I; Kim DK; Yu N; Sung N; Lee SH; Park JE; Yang YJ
PLoS One; 2021; 16(12):e0260850. PubMed ID: 34905589
[TBL] [Abstract][Full Text] [Related]
38. Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library.
Kim YJ; Lee MH; Lee SR; Chung HY; Kim K; Lee TG; Kim DY
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671877
[TBL] [Abstract][Full Text] [Related]
39. Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1.
Yang G; Li Z; Mohammed I; Zhao L; Wei W; Xiao H; Guo W; Zhao Y; Qu F; Huang Y
Signal Transduct Target Ther; 2021 Jun; 6(1):227. PubMed ID: 34112756
[No Abstract] [Full Text] [Related]
40. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
